Adapting a complex violence prevention intervention.

Reconstructing Africa’s demographic past. Exploring new sources, methods and technologies to uncover long-term population trends.

The Afya Consortium for research on public health threats in populations affected by crises: a multi-disciplinary, collaborative research programme

AMBITION (High Dose AMBISOME on a Fluconazole Backbone for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: A Randomised Controlled Non-inferiority Trial) is a four-year project funded at just under €10M by the European and Developing Countries Clinical Trials Partnership, the Swedish International Development Agency and the DFID/MRC/Wellcome Trust Joint Global Health Trials Fund. It runs from 1 January 2017 – 31 December 2020 across a consortium of five European and six African partners.

The AMRnet project aims to develop a data-visualisation dashboard that makes genome-derived antimicrobial resistance (AMR) data accessible to a wide range of stakeholders including policy makers.

We develop perspectives on antimicrobial resistance that draw from social theories about medicines, care, technologies, infrastructures, global arrangements on health, multi-species interactions, futures and more.

The Anti-fibrinolytics Trialists Collaboration (ATC) is an international collaboration to conduct individual patient data meta-analyses of results from randomised trials of anti-fibrinolytics versus placebo.

Fresh approaches to the study of antimicrobials in society.

Ayurveda for Promoting Recovery In Long COVID (APRIL) is a randomised trial examining whether a traditional Indian herbal medicine benefits adults suffering with long-term symptoms of COVID-19 (Long COVID) in the UK.